DTC User Fees Rejected By House Approps Panel As FDA Safety Funds Get Boost
Executive Summary
The House Appropriations Committee opted for using federal money, rather than fees from industry, to finance speedier FDA review of direct-to-consumer television ads when it approved a $1.7 billion fiscal year 2008 funding package for the agency July 19
You may also be interested in...
FDA’s Sequestered User Fees From FY 2013 Likely Gone, But FY 2014 Fees Could Be Exempted
Rep. Farr says Congressional Budget Office scoring problems could not be overcome, meaning FY 2013 FDA user fees lost to sequester may not be recovered, but amendment will be proposed to ensure FY 2014 fees are not lost in the upcoming appropriations bill.
FDA Largely Ignored At Appropriations Subcommittee Mark-Up
Rep. DeLauro proposes only amendment, which did not affect FDA and was defeated, but also warns FDA cuts could endanger Americans’ health.
Translational Science Center Mission And Budget Draw Congress’ Scrutiny
House Appropriations subcommittee Republicans seem concerned about whether the National Center for Advancing Translational Sciences will step on industry toes, which could lead to a more tightened focus for the new NIH center’s funding in the fiscal 2013 budget.